ArticleBMC women's health2025
Interval between diagnosis and treatment of cervical cancer in Brazil: comparative analysis of cases with and without diagnosis prior to arrival at the hospital unit.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTimely initiation of cancer treatment is essential to improving outcomes and reducing mortality. In Brazil, Federal Law No. 12.732/12 mandates that patients with confirmed cancer diagnoses begin treatment within 60 days. This study aimed to assess compliance with this law among women diagnosed with cervical cancer, comparing cases with and without a prior diagnosis at the time of hospital admission.
methodsEcological study of temporary series, based on data from the Integrator of Hospital Cancer Records (IRHC). The cases were divided into two groups (cases diagnosed during hospital care and those with a previous diagnosis) and analyzed in the periods before (2006 to 2012) and after the enactment of the law (2013 to 2019). The percentage trend of adherence was analyzed by the Joinpoint Regression Program.
resultsAmong 120,311 eligible cases, 31.7% (n = 38,143) were diagnosed at the hospital, and 68.3% (n = 82,168) had a prior diagnosis. Overall, 43.2% of women initiated treatment within 60 days. After the law was enacted, the proportion of timely treatment decreased to 66.7% in the no prior diagnosis group and 28.7% in the prior diagnosis group. Significant regional and interstate disparities were observed. Joinpoint analysis revealed both increasing and decreasing trends across states, with notable declines in timely treatment among women with a prior diagnosis.
conclusionCompliance with the 60-day treatment law remains suboptimal, particularly among women with a prior cervical cancer diagnosis. These disparities suggest persistent barriers in patient navigation and systemic inefficiencies within Brazil's public healthcare network. Our findings underscore the need for strengthening integrated care pathways and implementing national patient navigation programs to ensure timely cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.